AU3657799A - Use of murine myosin heavy chain promoters for gene therapy and production of transgenics - Google Patents

Use of murine myosin heavy chain promoters for gene therapy and production of transgenics

Info

Publication number
AU3657799A
AU3657799A AU36577/99A AU3657799A AU3657799A AU 3657799 A AU3657799 A AU 3657799A AU 36577/99 A AU36577/99 A AU 36577/99A AU 3657799 A AU3657799 A AU 3657799A AU 3657799 A AU3657799 A AU 3657799A
Authority
AU
Australia
Prior art keywords
transgenics
production
heavy chain
gene therapy
myosin heavy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36577/99A
Inventor
Jeffrey Robbins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cincinnati Childrens Hospital Medical Center
Original Assignee
Cincinnati Childrens Hospital Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cincinnati Childrens Hospital Medical Center filed Critical Cincinnati Childrens Hospital Medical Center
Publication of AU3657799A publication Critical patent/AU3657799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/107—Rabbit
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0368—Animal model for inflammation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Environmental Sciences (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU36577/99A 1998-04-20 1999-04-20 Use of murine myosin heavy chain promoters for gene therapy and production of transgenics Abandoned AU3657799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8235298P 1998-04-20 1998-04-20
US60082352 1998-04-20
PCT/US1999/008710 WO1999054491A1 (en) 1998-04-20 1999-04-20 Use of murine myosin heavy chain promoters for gene therapy and production of transgenics

Publications (1)

Publication Number Publication Date
AU3657799A true AU3657799A (en) 1999-11-08

Family

ID=22170664

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36577/99A Abandoned AU3657799A (en) 1998-04-20 1999-04-20 Use of murine myosin heavy chain promoters for gene therapy and production of transgenics

Country Status (2)

Country Link
AU (1) AU3657799A (en)
WO (1) WO1999054491A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030060772A (en) * 2000-05-05 2003-07-16 지티씨바이오쎄라퓨틱스,인크. Transgenically produced decorin
CN1329091A (en) * 2000-06-21 2002-01-02 上海博德基因开发有限公司 A novel polypeptide-human tropobidin 9 and polynucleotide for coding this polypeptide
FR2943249B1 (en) * 2009-03-18 2011-08-12 Genethon USE OF DECORINE TO INCREASE MUSCLE MASS
CN115992178A (en) * 2022-08-08 2023-04-21 首都医科大学附属北京天坛医院 Preparation method and application of decorin transgenic mice

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310441D0 (en) * 1993-05-20 1993-07-07 Royal Free Hosp School Med Gene therapy
US5917123A (en) * 1997-03-14 1999-06-29 University Of Pittsburgh Transgenic mice containing a nucleic acid encoding tumor necrosis factor-α under the control of a cardiac specific regulatory region
US6218597B1 (en) * 1997-04-03 2001-04-17 University Technology Corporation Transgenic model and treatment for heart disease
GB9708526D0 (en) * 1997-04-25 1997-06-18 Royal Free Hosp School Med Eukaryotic gene expression cassette and uses thereof

Also Published As

Publication number Publication date
WO1999054491A1 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
IL148786A0 (en) Methods and microorganisms for production of panto-compounds
AU5013100A (en) Maize rs81 promoter and methods of use thereof
AU9382998A (en) Corrosion resistant abrasive article and method of making
HK1043280A1 (en) Purified and isolated piwi family genes and gene products and methods employing same
AU6695398A (en) Immunoadhesins and methods of production and use thereof
AU4367700A (en) Human kinesins and methods of producing and purifying human kinesins
HUP9800574A3 (en) Promoter of the cdc 25b gene, its preparation and use
AU5815699A (en) Prostate specific promoter and regulation of gene expression
AU6271598A (en) Targeted modification of the ccr-5 gene
AU3657799A (en) Use of murine myosin heavy chain promoters for gene therapy and production of transgenics
AU3467099A (en) Methods for production of therapeutic cytokines
AU4397797A (en) Method of gene introduction
HUP0004931A3 (en) Synthesis of betha-lactam antibacterials using soluble side chain esters and enzyme acylase, intermediates
AU6254799A (en) Anti-ige gene therapy
AU5683298A (en) Arrangement of drilling and production ship
AU6116798A (en) Production method of iron carbide
ZA983216B (en) Process of inactivation of genes which codify for enzymes of the catabolysm of phenylacetate plasmides which intervene and strains transformed with the same
IL131043A0 (en) Microorganisms with increased production of clavulanic acid
GB9929061D0 (en) Methods of producing novel enzymes
AU1158895A (en) Enzymatic acylation of 3-hydroxymethly cephalosporins
AU2288301A (en) Production of recombinant organisms
AU2271701A (en) Inhibitors of interleukin 5 gene expression
AU2584699A (en) Immediate early genes and methods of use therefor
AU1040700A (en) The genetic determination of genes and its use for the prophylaxis and therapy of diseases
AU4985200A (en) Methods of treating hypertension

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase